Personal information

HIV, neutralizing antibodies, HIV entry, virus diagnostics, Influenza
Switzerland

Activities

Employment (2)

Universität Zürich: Zurich, ZH, CH

Employment
Source: check_circle
University of Zurich

University of Zurich: Zurich, CH

2008-03-01 to present | Director/Professor (Institute of Medical Virology)
Employment
Source: Self-asserted source
Alexandra Trkola

Funding (21)

RENEW clinical studies in people with HIV

2023-10 to 2026-09 | Grant
Bill & Melinda Gates Foundation (Seattle, Washington, US)
Source: Self-asserted source
Alexandra Trkola

Profiling Humoral Immunity in Early Infection and Long-term Antiretroviral Therapy in the Zurich Primary HIV Infection Study

2023 to 2024 | Grant
Gilead Sciences (CA, CA, US)
Source: Self-asserted source
Alexandra Trkola

Uncovering HIV-1 envelope signatures linked with broadly neutralizing antibody evolution

2023 to 2024 | Grant
Novartis Foundation (Basel, CH)
Source: Self-asserted source
Alexandra Trkola

Imprinting broadly neutralizing antibody responses to HIV-1

2021-04-01 to 2025-03-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 201266
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

A Systematic Assessment of the Drivers of COVID-19 in the Swiss HIV Cohort Study: Epidemiology, Immunology, and Genetics

2021-01-01 to 2022-12-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 196906
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

COVID-19 RFP Research Program COMMIT

2021 to 2022 | Grant
Gilead Sciences (CA, CA, US)
GRANT_NUMBER:

IN-SW-983-6078

Source: Self-asserted source
Alexandra Trkola

HIV-1 Transmission in Switzerland: viral transmission traits, superinfection and drug resistance

2018-05-01 to 2022-04-30 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 179571
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Understanding HIV-1 broadly neutralizing antibody evolution - The Swiss 4.5K Screen

Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Transmission of influenza virus from asymptomatic healthcare workers and inpatients in the acute care hospital setting: A prospective study over two consecutive influenza seasons

The role of humoral immunity in HIV infection - Understanding broadly neutralizing antibody evolution

Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Defining determinants of broadly neutralizing antibody evolution in viral infection to guide vaccine development

2014 to 2016 | Grant
Swiss Vaccine Research Institute (Lausanne, CH)
Source: Self-asserted source
Alexandra Trkola

The role of humoral immunity in HIV infection

2011-04-01 to 2014-03-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 135527
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Development and analysis of mathematical models for the quantification of the number of antibodies needed for virus neutralization, and for estimating the rates at which viral escape variants arise under selection pressure induced by the antibody response

2011-01-01 to 2013-12-31 | Grant
Deutsche Forschungsgemeinschaft (Bonn, DE)
GRANT_NUMBER: 200991120
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

HIV-envelope-specific DARPin-based microbicide strategies

2009-09-15 to 2014-08-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: R01AI084133
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

The role of humoral immunity in HIV infection

2008-04-01 to 2011-03-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 120739
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Humoral immunity to HIV-1: Analysis of the function of antibody responses as correlate and surrogate marker of viremia control

Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

HIV entry: a target for the host immune response and antiviral approaches

Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Analysis of the correlates of protection in structured intermittent therapy: An in vivo model of acute HIV infection?

Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Interactions between HIV-1, glycosaminoglycans and the CC-chemo- kine RANTES: Implications for the early steps in virus life cycle

Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Identification and characterization of a neutralizing region on GP41 of HIV-1

1997-10-25 to 2001-02-28 | Grant
FWF Austrian Science Fund (Vienna, AT)
GRANT_NUMBER: P 12548
Source: Self-asserted source
Alexandra Trkola via DimensionsWizard

Resistenz primärer HIV-1 Viren gegen Neutralisation

1995-08-01 to 1996-07-31 | Grant
FWF Austrian Science Fund (Vienna, AT)
GRANT_NUMBER:

J 1165

Source: Self-asserted source
Alexandra Trkola via DimensionsWizard